Apple Sales Miss Estimates on Sluggish Economy, Supply Snags

(Bloomberg) —

Apple Inc. reported a steeper sales decline in its holiday period than Wall Street feared, showing the toll of an economic slowdown and lingering supply snags.

Revenue in the fiscal first quarter amounted to $117.2 billion, the company said in a statement Thursday. That compared with Wall Street projections of about $121.1 billion. The shares fell in extended trading.

The results show that Apple hasn’t been able to dodge the tech slowdown afflicting many of its competitors. Demand for smartphones and computers has slumped in the past year, and Covid-19 restrictions in China added to Apple’s woes during the holiday sales period. Timing was another issue: The company didn’t launch new Macs and HomePods until recent weeks, missing the end of the first quarter.

Earnings came in at $1.88 per share, compared with an average estimate of $1.94 per share. The Cupertino, California-based technology giant didn’t provide a revenue outlook for the second quarter, continuing an approach it adopted at the start of the Covid pandemic in 2020.

Read more: How Apple timed the launch of its new Macs, HomePod

Apple shares had closed up 3.7% at $150.82 in New York. They have gained 16% this year.

Chief Executive Officer Tim Cook cited a “challenging environment” in the statement. “We remain focused on the long term,” he said.

Apple generated $65.8 billion from its flagship product, the iPhone, missing the estimate of $68.3 billion. That also represents a decline the $71.6 billion that the product brought in a year earlier. While the latest iPhone was a more significant leap than the previous version, the factories producing the popular Pro models in China were shuttered for several weeks during the quarter due to pandemic restrictions.

The company made $7.74 billion from the Mac, well short of the $9.7 billion estimate. That’s also a significant drop from $10.9 billion a year ago.

It was a tough year-over-year comparison given that Apple launched a revamped MacBook Pro line in the previous holiday period. This time around, it didn’t update the MacBook Pro and Mac mini models until the current quarter.

(Updates with product sales in seventh paragraph.)
By Mark Gurman

Follow us on social media for the latest updates in B2B!

Image

Latest

Get a feel for Benchmark Products cleanroom solutions for life sciences manufacturing customers with this mini tour of their facility.
Tour Benchmark Products: Pioneering Cleanroom Solutions for Life Sciences
April 26, 2024

Get a feel for Benchmark Products cleanroom solutions for life sciences manufacturing customers with this mini tour of their facility.

Read More
bioprocessing solutions
Benchmark Products Bioprocessing Solutions Provide Single-Use Solutions for Customers
April 26, 2024

Benchmark provides a new bioprocessing solution to maximize efficiency. This is a single-use system for pharma manufacturers for filling, mixing and single-use assemblies.

Read More
Interphex
Benchmark at Interphex 2024
April 26, 2024

Benchmark Products showcased their line of life science and pharmaceutical manufacturing products during Interphex in New York City April 2024.

Read More
cyber risk management in healthcare
Navigating Cyber Risk Management in Healthcare Means Handling the Small Alerts and Big Alarms
April 26, 2024

In an era where digital dependencies are integral to healthcare operations, cyber risk management in healthcare requires addressing the big events and attending to the small ones. This urgent need to address and mitigate cyber vulnerabilities was a key discussion point during a MarketScale Experts Talk discussion on continued cybersecurity threats in healthcare. The […]

Read More